Earlier this month, Humana cut its full-year earnings outlook, citing ongoing pressure in its Medicare Advantage business ...

The insurer continues to try to prove that regulators acted arbitrarily in downgrading its quality scores for 2025, despite ...

Humana AB has announced the acquisition of Familiehjelpgruppen AS, a respected provider of family-based care services in Norway. This acquisition will enhance Humana’s capacity in foster homes and ...

Humana Inc. is working with billionaire Mark Cuban on a potential pharmacy partnership, Cuban and Humana’s chief executive ...

Humana (HUM) stock has remained sideways for the year with the company lowering its full-year earnings outlook. While Humana ...

Humana is again trying to win its lawsuit against the Centers for Medicare and Medicaid Services over its star ratings ...

Humana has been upgraded by Jefferies based on its diversification strategy for its Medicare Advantage offerings. The upgrade ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $230.0 and $280.0 for Humana, spanning the last three months.

Mark Cuban's Cost Plus Drugs and Humana are exploring a potential partnership to help lower the cost of prescription drugs ...

Humana Healthy Horizons in Oklahoma awards $295,500 to six organizations tackling food, housing and health access challenges.

Humana (HUM) has been upgraded to Buy at Jefferies, driven by a significantly improved earnings outlook. Read more here.